Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s Disease: A retrospective cohort study

International Journal of Impotence Research, Published online: 16 January 2024; doi:10.1038/s41443-023-00810-5Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s Disease: A retrospective cohort study

Source: International Journal of Impotence Research - January 16, 2024 Category: Urology & Nephrology Authors: Emil Durukan Rune Kraglund Shad Azad Rashid Tine Thorkilgaard Christian Fuglesang Skj ødt Jensen Mikkel Fode Source Type: research